Insider trades
Carter Todd Alfred, Chief Officer of Voyager Therapeutics VYGR, has filed 0 purchases and 18 sales on the open market. Over the past 12 months that comes to a net sale of $40.6K. The latest trade was on 02/24.
Carter Todd Alfred
Chief Scientific Officer
- Company
- Voyager Therapeutics VYGR
- First filing
- 23/01/10
- Trades
- 31 trades
- Buys / sales
- 0 / 18
- 12-month net buying
- −$40.6K
- Last trade
- 02/24
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 02/24 | 02/26 | 4,174 sh | $3.76 | $15,694.24 | −2.8% | |
| Open-market sale10b5-1 plan | 02/18 | 02/20 | 3,301 sh | $3.44 | $11,355.44 | −2.2% | |
| Open-market sale | 02/10 | 02/11 | 3,525 sh | $3.85 | $13,571.25 | −2.2% | |
| Open-market sale | 25/02/20 | 25/02/24 | 3,305 sh | $4.26 | $14,079.3 | −4.1% | |
| Open-market sale | 25/02/11 | 25/02/12 | 5,413 sh | $4.45 | $24,087.85 | −6.3% | |
| Open-market sale | 25/01/14 | 25/01/15 | 1,191 sh | $5.13 | $6,109.83 | −1.4% | |
VYGR | Open-market sale | 24/02/20–24/02/21 | 24/02/22 | 3,967 sh2 trades | $7.50avg. | $29,759.91 | −4.3% |
| Open-market sale | 24/01/17 | 24/01/19 | 1,266 sh | $7.18 | $9,089.88 | −2.3% | |
| Open-market sale10b5-1 plan | 23/09/15 | 23/09/18 | 10,500 sh | $8.16 | $85,680 | −16.2% | |
| Open-market sale10b5-1 plan | 23/07/06 | 23/07/10 | 5,500 sh | $10.80 | $59,400 | −8.4% | |
| Open-market sale10b5-1 plan | 23/06/30 | 23/07/05 | 5,000 sh | $11.41 | $57,050 | −7.1% | |
| Open-market sale | 23/03/20 | 23/03/22 | 2,193 sh | $7.76 | $17,017.68 | −3.2% | |
| Open-market sale | 23/02/17 | 23/02/22 | 738 sh | $7.45 | $5,498.1 | −1.1% | |
| Open-market sale | 23/02/13 | 23/02/15 | 797 sh | $7.67 | $6,112.99 | −2.3% | |
VYGR | Open-market sale | 23/01/17 | 23/01/19 | 1,106 sh2 trades | $9.85avg. | $10,892.42 | −3.1% |
| Open-market sale | 23/01/06 | 23/01/10 | 388 sh | $6.41 | $2,487.08 | −1.1% |